IMPERIAL COLLEGE LONDON DIABETES CENTRE OPENS REGISTRATION FOR 2022 COURSE FOR ASPIRING PATIENT EDUCATORS

39

New format increases access to one-year programme for healthcare workers in the UAE who wish to hone their skills in diabetes management or education

Dr Nader Lessan, a consultant endocrinologist and diabetologist at ICLDC

Abu Dhabi, United Arab Emirates: Mubadala Health’s Imperial College London Diabetes Centre (ICLDC) has opened registration for its popular professional development course in diabetes management. For the second year, it is being offered in a revised format with online components, thus extending access to healthcare workers across the UAE, with courses starting from January.

ICLDC began offering the Imperial Diabetes Educator Training Course (IDET) in 2014. The multidisciplinary programme equips healthcare employees to work in diabetes education and management in a variety of settings. Taught over a year, the course is open to nurses, dietitians, pharmacists and other healthcare workers with a current licence to practise.

Dr Nader Lessan, a consultant endocrinologist and diabetologist at ICLDC and director of the programme, says: “This course is part of ICLDC’s commitment to contribute to the entire healthcare system in Abu Dhabi, and to promote knowledge transfer in endocrinology, diabetes management and advanced medicine across the region. More than 79 graduates have successfully completed the course and have furthered their careers in diabetes education and management since it began.”

He adds: “As the burden of diabetes continues to escalate around the world, so does the need for a new generation of diabetes educators who can teach patients and their carers how to take charge of their conditions, while also raise awareness and educate the community on diabetes testing and good lifestyle habits. Now that we are offering the course online, we have been able to increase access to the latest tools, resources and expert knowledge to prepare more professionals here and in the region.”

The 2022 cohort will be able to attend online lectures that cover the theoretical aspects of diabetes management and patient education, while the practical component is completed at ICLDC’s facilities in Abu Dhabi. The course will be held every Wednesday from 5:30pm – 7:30pm (UAE), with supplementary lessons on select Mondays.

The course is held in partnership with Imperial College London and includes case seminars and clinical training on chronic disease self-management education, applied biological and behavioural sciences, principles of teaching and learning, and best practice management of diabetes. Graduates will be eligible to be licenced as Health Educators by the Department of Health – Abu Dhabi (DOH).

Interested applicants should be licensed healthcare professionals (by Department of Health – Abu Dhabi, Dubai Health Authority or Ministry of Health) in fields such as nursing, dietetics or pharmacy and be fluent in English (IELTS or equivalent). Applicants need to pass an ICLDC entry interview to be participate.

About Mubadala Health:

Mubadala Health is the integrated healthcare network of Mubadala Investment Company. Established in 2021, Mubadala Health operates, manages, and develops a portfolio of healthcare assets including: Cleveland Clinic Abu Dhabi, Healthpoint, Imperial College London Diabetes Centre (ICLDC), Amana Healthcare, National Reference Laboratory (NRL), Capital Health Screening Centre (CHSC), Abu Dhabi Telemedicine Centre (ADTC), Danat Al Emarat, HealthPlus Diabetes & Endocrinology Center, HealthPlus Family Clinics, HealthPlus Fertility, HealthPlus Women’s Health Center, Moorfields Eye Hospital Abu Dhabi, and a stake in Al Meswak Dental Clinics Group. With a vision to transform the regional healthcare landscape, Mubadala Health sets a new benchmark for the UAE and regional healthcare industry through its state-of-the-art facilities and world-class caregivers who strive to put patients first across its continuum of care. Innovation, research, and education are the foundational pillars of Mubadala Health, supporting the further development of a sustainable healthcare sector in line with the vision of Abu Dhabi and the region.

Mubadala Health is on Twitter, Instagram, Facebook and LinkedIn with the handle: @mubadalahealth.

About Imperial College London Diabetes Centre:

Imperial College London Diabetes Centre (ICLDC), a Mubadala Health partner, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness. In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.

With more than 80 diabetes professionals and endocrinologists under one roof, ICLDC offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre- and post-bariatric surgery care, heart disease prevention, nutritional advice, diabetes education services, ophthalmology, nephrology and podiatry.

ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates three branches across Abu Dhabi and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives. In 2007, ICLDC launched Diabetes. Knowledge. Action, now the longest running public health awareness campaign in the country. The initiative promotes an active lifestyle through an ongoing calendar of events for the whole community – Major activations include an annual walkathon that coincides with the World Diabetes Day in November. ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.